Based in Ft. Lauderdale, FL, ImmunoSite Technologies, LLC (IST) offers a full range of contract research (CRO) immune monitoring services to leading biotechnology, pharmaceutical, and academic organizations around the world to provide products and services that span all stages of drug discovery and development. The company is uniquely qualified to develop assays and conduct testing to assess immune status and function. IST is rapidly building a worldwide reputation for services related to qualifying, standardizing, and when appropriate, automating assays associated with cell-mediated immunity. IST services include flow cytometry, particle characterization, application development, automation, assay development and testing. By using qualified reagents, controls, standards and processes, IST-developed functional assays perform within tight specifications and yield reproducible results, helping pharmaceutical and biotechnology companies to accelerate drug discovery, document clinical relevance and reduce costs. A privately held company, IST was formed in August, 2009, to bring together a highly qualified team of industry leading immune system research and development scientists who together have more than 100 years of experience developing and performing assays related to immune monitoring and surveillance. The IST team has been distinguished by their ongoing partnerships with best-in-class clinical trial organizations such as: the Immune Tolerance Network, the Immune Tolerance Institute, and the Imperial College of London managed CD4 Initiative. This extensive cell analysis R&D experience qualifies IST scientists to comply with complex and demanding international scientific and governmental regulations.
View Top Employees from ImmunoSite TechnologiesWebsite | http://www.immunositetechnologies.com |
Revenue | $5 million |
Funding | $34000 |
Employees | View employees |
Address | PO Box 165937, Miami, Florida 33116, US |
Phone | (954) 462-6800 |
Industry | Business Services General, Business Services |
Competitors | CellCarta Formerly Caprion, DNA Link, Oceanic Consulting Corporation, SynChem, Inc., Theradex Oncology |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular ImmunoSite Technologies employee's phone or email?
The ImmunoSite Technologies annual revenue was $5 million in 2024.
ImmunoSite Technologies is based in Miami, Florida.
The NAICS codes for ImmunoSite Technologies are [541714, 541, 54, 54171, 5417].
The SIC codes for ImmunoSite Technologies are [873, 87].